查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1748727

精準醫療供應鏈物流市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、服務、產品、最終用戶、地區和競爭細分，2020-2030 年）

Precision Medicine Supply Chain Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Service, By Product, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球精準醫療供應鏈物流市場價值為 75.1 億美元，預計到 2030 年將達到 142.5 億美元，複合年成長率為 11.24%。隨著腫瘤、罕見疾病和遺傳疾病個人化治療的應用日益廣泛，該市場正在迅速擴張。精準醫療需要運送高度敏感的生物製劑、細胞和基因療法以及客製化診斷——每種都需要精確、溫控、時間關鍵和針對患者的物流解決方案。截至 2025 年，全球有超過 17,000 項與精準醫療相關的臨床試驗，對敏捷且合規的物流基礎設施的需求激增。物流供應商越來越關注安全的逆向物流、完全可追溯性和從站點到病患的配送等能力。包括物聯網感測器、區塊鏈和即時分析在內的增強技術正在推動這一領域的創新。分散試驗的興起也推動物流模式變得更加靈活和以患者為中心，特別是對於複雜治療方案中直接面向患者的配送。

市場概覽
預測期 2026-2030
2024年市場規模 75.1億美元
2030年市場規模 142.5億美元
2025-2030 年複合年成長率 11.24%
成長最快的領域 核酸療法
最大的市場 北美洲

關鍵市場促進因素

細胞和基因療法的採用率不斷上升

主要市場挑戰

處理個人化治療的複雜性很高

主要市場趨勢

直接面向病患（DTP）服務模式的出現

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球精準醫療供應鏈物流市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（臨床、商業）
    • 按服務（運輸、倉儲、採購、其他）
    • 依產品（細胞和基因療法（CGT）、單株抗體、核酸療法、疫苗等）
    • 按最終用戶（製藥和生物製藥公司、臨床研究組織等）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美精準醫療供應鏈物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲精準醫療供應鏈物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太精準醫療供應鏈物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲精準醫療供應鏈物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲精準醫療供應鏈物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Almac Group Limited
  • Catalent, Inc.
  • Parexel International Corporation
  • IQVIA Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • DHL International GmbH
  • Federal Express Corporation
  • UPS Healthcare
  • GXO Logistics, Inc.
  • Marken Limited

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29613

The Global Precision Medicine Supply Chain Logistics Market was valued at USD 7.51 Billion in 2024 and is projected to reach USD 14.25 Billion by 2030, registering a CAGR of 11.24%. This market is expanding rapidly due to the growing adoption of personalized treatments for oncology, rare diseases, and genetic conditions. Precision medicine demands the transportation of highly sensitive biologics, cell and gene therapies, and customized diagnostics-each requiring precise, temperature-controlled, time-critical, and patient-specific logistics solutions. With over 17,000 active precision medicine-related clinical trials worldwide as of 2025, the need for agile and compliant logistics infrastructure has surged. Logistics providers are increasingly focused on capabilities such as secure reverse logistics, full traceability, and site-to-patient delivery. Enhanced technologies-including IoT sensors, blockchain, and real-time analytics-are driving innovation in this space. The rise in decentralized trials is also pushing logistics models to be more flexible and patient-centric, especially for direct-to-patient delivery in complex therapy regimens.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 7.51 Billion
Market Size 2030USD 14.25 Billion
CAGR 2025-203011.24%
Fastest Growing SegmentNucleic Acid Therapies
Largest MarketNorth America

Key Market Drivers

Rising Adoption of Cell and Gene Therapies

The increasing use of cell and gene therapies is a key growth driver in the Precision Medicine Supply Chain Logistics Market. These personalized treatments involve a complex, highly regulated sequence-from harvesting patient samples to lab processing and returning the final product-all under strict time and temperature constraints. In 2023 and 2024 alone, the FDA approved a total of 16 cell and gene therapy products, indicating strong regulatory momentum and growing manufacturing needs. These sensitive therapies require ultra-cold or cryogenic transport to maintain integrity, driving demand for advanced cold-chain logistics, real-time GPS monitoring, and compliance-driven documentation. Providers offering complete traceability, contingency protocols, and certified infrastructure are becoming essential partners for biopharma companies.

Key Market Challenges

High Complexity of Handling Personalized Therapies

Managing personalized therapies presents significant operational challenges in the precision medicine logistics ecosystem. Unlike standard pharmaceuticals, these treatments are custom-made for individual patients and must adhere to narrow time windows and stringent environmental controls. For instance, autologous therapies involve transporting a patient's own cells to and from a specialized facility, necessitating seamless coordination, temperature integrity, and accurate labeling throughout the chain of custody. Any error-be it in customs clearance, labeling, or timing-can jeopardize treatment viability. Each shipment must align precisely with clinical and patient schedules, leaving virtually no room for deviation and amplifying the logistical complexity.

Key Market Trends

Emergence of Direct-to-Patient (DTP) Delivery Models

The growing prominence of Direct-to-Patient (DTP) delivery models is reshaping precision medicine logistics. As therapies become increasingly individualized, delivering treatment directly to patients' homes enhances accessibility and supports decentralized clinical trials. This model improves convenience, adherence, and participation, particularly for patients in remote or mobility-limited settings. DTP logistics requires precise coordination, validated cold-chain packaging, and real-time tracking systems to maintain therapy integrity during transit. Cold chain continuity and regulatory compliance are critical, especially for sensitive biologics. Logistics providers are investing in digital infrastructure and white-glove services-such as in-person delivery, patient education, and reverse logistics-to meet these complex demands. With the continued growth of telehealth and at-home diagnostics, DTP delivery is becoming integral to modern, patient-focused precision medicine.

Key Market Players

  • Almac Group Limited
  • Catalent, Inc.
  • Parexel International Corporation
  • IQVIA Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • DHL International GmbH
  • Federal Express Corporation
  • UPS Healthcare
  • GXO Logistics, Inc.
  • Marken Limited

Report Scope:

In this report, the Global Precision Medicine Supply Chain Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Precision Medicine Supply Chain Logistics Market, By Type:

  • Clinical
  • Commercial

Precision Medicine Supply Chain Logistics Market, By Service:

  • Transportation
  • Warehousing
  • Sourcing & Procurement
  • Others

Precision Medicine Supply Chain Logistics Market, By Product:

  • Cell & Gene Therapies (CGT)
  • Monoclonal Antibodies
  • Nucleic Acid Therapies
  • Vaccines
  • Others

Precision Medicine Supply Chain Logistics Market, By End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Clinical Research Organizations
  • Others

Precision Medicine Supply Chain Logistics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Precision Medicine Supply Chain Logistics Market.

Available Customizations:

Global Precision Medicine Supply Chain Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Precision Medicine Supply Chain Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Clinical, Commercial)
    • 5.2.2. By Service (Transportation, Warehousing, Sourcing & Procurement, Others)
    • 5.2.3. By Product (Cell & Gene Therapies (CGT), Monoclonal Antibodies, Nucleic Acid Therapies, Vaccines, Others)
    • 5.2.4. By End User (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Others)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Precision Medicine Supply Chain Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Service
    • 6.2.3. By Product
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Precision Medicine Supply Chain Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Service
        • 6.3.1.2.3. By Product
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Precision Medicine Supply Chain Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Service
        • 6.3.2.2.3. By Product
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Precision Medicine Supply Chain Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Service
        • 6.3.3.2.3. By Product
        • 6.3.3.2.4. By End User

7. Europe Precision Medicine Supply Chain Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Service
    • 7.2.3. By Product
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Precision Medicine Supply Chain Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Service
        • 7.3.1.2.3. By Product
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Precision Medicine Supply Chain Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Service
        • 7.3.2.2.3. By Product
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Precision Medicine Supply Chain Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Service
        • 7.3.3.2.3. By Product
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Precision Medicine Supply Chain Logistics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Service
        • 7.3.4.2.3. By Product
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Precision Medicine Supply Chain Logistics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Service
        • 7.3.5.2.3. By Product
        • 7.3.5.2.4. By End User

8. Asia-Pacific Precision Medicine Supply Chain Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Service
    • 8.2.3. By Product
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Precision Medicine Supply Chain Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Service
        • 8.3.1.2.3. By Product
        • 8.3.1.2.4. By End User
    • 8.3.2. India Precision Medicine Supply Chain Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Service
        • 8.3.2.2.3. By Product
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Precision Medicine Supply Chain Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Service
        • 8.3.3.2.3. By Product
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Precision Medicine Supply Chain Logistics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Service
        • 8.3.4.2.3. By Product
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Precision Medicine Supply Chain Logistics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Service
        • 8.3.5.2.3. By Product
        • 8.3.5.2.4. By End User

9. South America Precision Medicine Supply Chain Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Service
    • 9.2.3. By Product
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Precision Medicine Supply Chain Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Service
        • 9.3.1.2.3. By Product
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Precision Medicine Supply Chain Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Service
        • 9.3.2.2.3. By Product
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Precision Medicine Supply Chain Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Service
        • 9.3.3.2.3. By Product
        • 9.3.3.2.4. By End User

10. Middle East and Africa Precision Medicine Supply Chain Logistics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Service
    • 10.2.3. By Product
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Precision Medicine Supply Chain Logistics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Service
        • 10.3.1.2.3. By Product
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Precision Medicine Supply Chain Logistics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Service
        • 10.3.2.2.3. By Product
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Precision Medicine Supply Chain Logistics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Service
        • 10.3.3.2.3. By Product
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Almac Group Limited
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Catalent, Inc.
  • 15.3. Parexel International Corporation
  • 15.4. IQVIA Holdings Inc.
  • 15.5. Thermo Fisher Scientific Inc.
  • 15.6. DHL International GmbH
  • 15.7. Federal Express Corporation
  • 15.8. UPS Healthcare
  • 15.9. GXO Logistics, Inc.
  • 15.10. Marken Limited

16. Strategic Recommendations

17. About Us & Disclaimer